RTP — Qualyst, announced the formation of its Business Advisory Board that includes Dr. Pamela Kirby, former Chief Executive Officer of Quintiles Transnational Corporation.

“The members of this advisory board are business leaders in both the pharmaceutical and financial industries,” said Scott Neuville, president and CEO of Qualyst. “Collectively, their expertise will assist Qualyst in its mission to provide novel ADMET technologies and products to the life sciences industry that will increase the efficiency and effectiveness of drug discovery and development.”

Qualyst’s Business Advisory Board now currently has two members.

Pamela Kirby, Ph.D., who was most recently Chief Executive Officer of Quintiles Transnational Corporation as previously mentioned is the first member. Previously, Kirby led the Global Strategic Marketing and Business Development department of the pharmaceutical division of F. Hoffmann-La Roche Ltd. in Basel, Switzerland.

The second member of the board is Jonathan Gelles, Chairman of Burton Advisers. Dr. Gelles obtained his D. Phil. in physical organic chemistry at Oxford University and has been active in the health sciences investment community for many years, both in the U.S. and Europe. He had previously held the position of Managing Director at Wertheim, Inc. in New York in the 1990s. Burton Advisers acted as the exclusive financial advisor and placement agent in the Qualyst Series A offering.

Qualyst, Inc. was founded on discoveries from research in the School of Pharmacy at the University of North Carolina at Chapel Hill and focuses on commercializing novel and proprietary ADMET products to drug discovery and development customers.

www.qualyst.com

Southeast Venture Conference, February 29 – March 1, 2012 at the Ritz Carlton in Tysons Corner, VA – Where Smart Money Meets Smart People.
www.seventure.org

© 2004, TechJournal South. All rights reserved.